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Phased by Notch
 
On page 157, Sarmento and colleagues show
how the developmental regulator protein
Notch1 advances the cell cycle. Activation of
Notch1 induced the production of a protein
that chops up cell cycle inhibitors, leading to a
shortened G1 phase and a faster transition into S
phase (but no overall increase in proliferation).
The Notch family of transmembrane re-
ceptors regulates both cell fate decisions and
the maintenance of adult stem cells, processes
that require precise control of the cell cycle.
Although Notch1 activation had previously been
shown to alter the cell cycle in hematopoietic
progenitor cells and to delay their commitment to
the myeloid lineage, a direct link between
Notch1 and cell cycle control pathways had not
been established in these cells.
Sarmento et al. now find the link and show
that constitutive Notch1 activation drives cell
cycling by increasing the activity of cyclin-
dependent kinase-2 (CDK2), a protein that
promotes progression into the S phase of the
cell cycle. CDK2 activation resulted from the
degradation of the CDK inhibitor protein
p27
 
kip1
 
, which was triggered by the Notch1-
induced expression of a protein called SKP2—
a component of a ubiquitin ligase complex that
targets proteins for proteosomal degradation.
How Notch-induced changes in cell cycle
kinetics influence differentiation programs is
not completely clear. The authors suggest that
a shortened G1 phase—during which cells are
thought to be most responsive to fate-deciding
differentiation signals—may minimize the window
of differentiation opportunity and thus help
maintain the progenitor cell pool.
Notch1 promotes progression into the S phase of 
the cell cycle by inducing the expression of SKP2, 
a component of a ubiquitin ligase complex that 
degrades the CDK inhibitor p27kip1.
 
Progenitor of all trades
 
Despite years of research, the identity of the bone marrow progenitor cells
that seed the thymus, as well as the place where they ultimately commit
to being T cells, have remained elusive. On page 21, Benz and Bleul
identify the first multipotent progenitor cell in the adult thymus. The new
data suggest that, for at least some progenitor cells, commitment to a T
cell fate occurs after arrival in the thymus.
Populations of thymic precursor cells have been shown to generate
multiple cell lineages, but it remains a matter of debate whether single
precursor cells can give rise to all the possible thymic cell lineages—T
cells, B cells, and dendritic cells (DCs).
Benz and Bleul now show that these cell types can indeed arise from a
single precursor cell. By fusing EGFP with a marker of T cell development
sites (CCR9), they pinpointed a small population of cells in the bone
marrow that was able to populate the thymus.
Single-cell sorting of these precursor cells from the thymus revealed that
a single cell could generate T cells, B cells and DCs, suggesting that these
progenitor cells commit to a T cell fate in the thymus. Thymic cells with
the same surface markers but lower levels of EGFP—presumably representing
a slightly more mature population of cells (with decaying EGFP)—were no
longer able to generate B cells, suggesting that the EGFP
 
 
 
 population marks
the branching point of the T and B cell lineages.
 
Stressed out and asthmatic
 
The ability to cope with stress may decrease 
susceptibility to asthma, according to 
Rangasamy and colleagues on page 47.
The absence of the transcription factor Nrf2, 
which helps cells respond to oxidative stress, 
exacerbated allergic responses in mice, leading 
senior author Shyam Biswal to speculate that 
inducers of the Nrf2 pathway may have 
therapeutic potential for the treatment of 
human asthma.
Asthma is a complex disorder that involves 
the recruitment of inflammatory cells, including 
eosinophils, to the lungs. Once there, these cells 
release reactive oxygen species (ROS), which are 
thought to contribute to lung tissue damage. 
Levels of ROS are normally counterbalanced by 
antioxidants, which are present at lower levels 
in the airways of asthma patients.
Here, Rangasamy and colleagues 
investigated the effect of oxidative stress on 
asthma in mice lacking Nrf2, which induces the 
expression of many antioxidant genes. They found that the lack of Nrf2 increased 
influx of cells into the airways, mucus production, airway hypersensitivity, and T 
helper 2 cytokine production—all characteristic symptoms of asthma—in response 
to challenge with an inhaled allergen.
Although the mechanisms involved remain largely unknown, the elevated 
cytokine levels likely resulted from increased activation of NF-
 
 
 
B, which is known 
to be activated by ROS. They now plan to look for alterations in the 
 
Nrf2
 
 gene in 
asthma-prone humans, as they think defects in this gene might contribute to 
susceptibility to disease.
Influx of eosinophils (brown) 
into the lungs is increased in 
the absence of the transcription 
factor Nrf2 (bottom).
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